Vectofusin ®-1 from Miltenyi Biotec

(1) Cell type-specific delivery by modular envelope designNat CommunAugust 23, 2023Daniel Strebinger, Chris J. Frangieh, Mirco J. Friedrich, Guilhem Faure, Rhiannon K. Macrae, Feng ZhangPolybrene (Santa Cruz Biotechnology Cat. # sc-134220) or 10 µg/ml of vectofusin (Miltenyi Biotec, Cat. # 130-111-163) were added. Spinoculations were performed at 1500 × g for 90 min at 33 °C. For DIRECTED tropism, the

(2) Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinomaImmunologyJune 1, 2023Lin Chen, Siyuan Liu, Dickson Adah, Qingyang Sun, Zhaoduan Liang, Mitchell Ho, Beicheng Sunlentiviral particles containing the CAR gene at a multiplicity of infection of 5. And vectofusin-1 (Cat: 130111163, Miltenyi Biotec) was used to promote lentiviral transduction of NK. After 48 h, the expression of CAR

(3) CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell FrequenciesVaccines (Basel)January 31, 2023Gamze Gulden, Berranur Sert, Tarik Teymur, Yasin Ay, Nulifer Neslihan Tiryaki, Abhinava K. Mishra, Ercument Ovali, Nevzat Tarhan, Cihan Tastan11082132001, 20 mg). Lentivirus transduction procedure, Vectofusin 1 (10 µg/mL) (Miltenyi Biotech, 130-111-163), and BX-795 hydrochloride (6 µM) (Millipore Sigma, Burlington, MA, USA, SML0694- 5MG) were inoculated

Be the First to Write a Review!

Vectofusin ®-1 from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (3)

Reviews

Vectofusin ®-1 from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map